SLC13A2 and nephrolithiasis: In contrast, PF-06761281 showed significant activity on the closely related transporters NaDC1 (gene symbol SLC13A2) and NaDC3 (gene symbol SLC13A3), leading to increased urinary calcium excretion [24], which may have unfavourable effects on bone health and kidney stone formation.